Items where Author is "Shaygannejad, Vahid"

(2021) Mizaj assessment in Multiple Sclerosis (MS) patients based on Persian Medicine. J Complement Integr Med. ISSN 1553-3840

(2021) Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Quantitative Magnetic Resonance Imaging Analysis of Early Markers of Upper Cervical Cord Atrophy in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis International. ISSN 2090-2654

(2021) Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinicaltrial. Int Immunopharmacol. p. 107715. ISSN 1567-5769

(2020) Association of helicobacter pylori with multiple sclerosis: Protective or risk factor? Current Journal of Neurology. pp. 59-66. ISSN 2717-011X

(2020) COVID-19 infection in a patient with multiple sclerosis treated with fingolimod. Neurology-Neuroimmunology & Neuroinflammation. ISSN 2332-7812

(2020) Characteristics of COVID-19 disease in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2020) Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. Journal of Clinical Medicine.

(2020) Comparison of Cognitive Rehabilitation versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression among Multiple Sclerosis Patients. Neurology Research International. ISSN 2090-1852

(2020) Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta. Iranian Journal of Allergy Asthma and Immunology. pp. 416-425. ISSN 1735-1502

(2020) Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire. Journal of Multidisciplinary Healthcare. pp. 609-613. ISSN 1178-2390

(2020) Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis. Cell J. pp. 92-95. ISSN 2228-5806 (Print) 2228-5806 (Linking)

(2020) Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD). Sleep Med. pp. 97-105. ISSN 1878-5506 (Electronic) 1389-9457 (Linking)

(2020) Effect of donepezil on cognitive impairment, quality of life, and depression in multiple sclerosis patients: A randomized clinical trial. International Journal of Preventive Medicine. ISSN 2008-7802

(2020) Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2020) Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated with Higher Prevalence of Falling among Individuals with the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (NMOSD). Journal of Clinical Medicine.

(2020) Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing-Remitting Multiple Sclerosis Patients? A Narrative Review. Neurology and Therapy. pp. 55-66. ISSN 2193-8253

(2020) Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? Journal of Molecular Neuroscience. pp. 1829-1835. ISSN 0895-8696

(2020) MS Care in Novel Coronavirus 19 Pandemic. International Journal of Preventive Medicine. ISSN 2008-7802

(2020) Progressive Multifocal Leukoencephalopathy as the First Manifestation of AIDS: A Rare Case Report. Archives of Clinical Infectious Diseases. ISSN 2345-2641

(2020) Quality of life among patients with multiple sclerosis and voiding dysfunction: a cross-sectional study. Bmc Urology. ISSN 1471-2490

(2020) Screening neuromyelitis optica patients for COVID-19 infection. Autoimmunity Reviews. ISSN 1568-9972

(2020) Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life. Bmc Urology. ISSN 1471-2490

(2020) Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis. Psychol Health Med. pp. 1-11. ISSN 1354-8506

(2020) Spiritual health in women with multiple sclerosis and its association with self-esteem. Journal of Education and Health Promotion. ISSN 2277-9531

(2020) Therapeutic plasma exchange may adjust IL-6 and TGF-beta signals in relapsed MS patients peripheral blood. Journal of Clinical Apheresis. pp. 72-78. ISSN 0733-2459

(2020) Upregulation ofMTOR,RPS6KB1, andEIF4EBP1in the whole blood samples of Iranian patients with multiple sclerosis compared to healthy controls. Metabolic Brain Disease. pp. 1309-1316. ISSN 0885-7490

(2020) The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis. Bmc Neurology.

(2020) The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis. Journal of Clinical Neuroscience. pp. 33-38. ISSN 0967-5868

(2019) Anti Mog, IgG-Nmo Antibody and Disability in Patients with Neuromyelitis Optica. Multiple Sclerosis Journal. pp. 115-116. ISSN 1352-4585

(2019) Association Study between Functional Polymorphisms of MMP9 Gene Promoter and Multiple Sclerosis Susceptibility in an Iranian Population. Iranian Journal of Public Health. pp. 1697-1703. ISSN 2251-6085

(2019) Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. Jama-Journal of the American Medical Association. pp. 175-187. ISSN 0098-7484

(2019) Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. J Neurol Neurosurg Psychiatry. pp. 458-468. ISSN 1468-330X (Electronic) 0022-3050 (Linking)

(2019) Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls. Mult Scler Relat Disord. pp. 81-87. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2019) Disease course, progression and activity of neuromyelitis optica (NMOSD) in patients who were treated with Rituximab, 6 and 12 months after receiving the first dose of drug, in Isfahan city. Multiple Sclerosis and Related Disorders. pp. 77-82. ISSN 2211-0348

(2019) Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients. J Immunoassay Immunochem. pp. 555-563. ISSN 1532-4230 (Electronic) 1532-1819 (Linking)

(2019) Evaluation of cognitive rehabilitation on the cognitive performance in multiple sclerosis: A randomized controlled trial. Journal of Research in Medical Sciences. p. 7. ISSN 1735-1995

(2019) Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica. Iranian Journal of Neurology. pp. 150-153. ISSN 2008-384X

(2019) Expression of OX40 Gene and its Serum Levels in Neuromyelitis Optica Patients. Biomol Concepts. pp. 62-67. ISSN 1868-503X (Electronic) 1868-5021 (Linking)

(2019) Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated from Newly Diagnosed and IFN-ss(1b)-Treated MS Patients. Inflammation. pp. 54-63. ISSN 0360-3997

(2019) In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise. Frontiers in Psychiatry. ISSN 1664-0640

(2019) Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study. Journal of Neurology. pp. 642-650. ISSN 0340-5354

(2019) Management of seizures in patients with multiple sclerosis; an Iranian consensus. Epilepsy & Behavior. ISSN 1525-5069 (Electronic) 1525-5050 (Linking)

(2019) Novel mutation in HTRA1 in a family with diffuse white matter lesions and inflammatory features. Neurology-Genetics. p. 8. ISSN 2376-7839

(2019) The Relationship between Salt Intake and Anti-Mog Levels in Patients with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal. pp. 71-72. ISSN 1352-4585

(2019) Serum levels of IL-6 and IL-17 in multiple sclerosis, neuromyelitis optica patients and healthy subjects. Int J Physiol Pathophysiol Pharmacol. pp. 267-273. ISSN 1944-8171 (Print) 1944-8171 (Linking)

(2019) Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In Vitro. Inflammation. ISSN 1573-2576 (Electronic) 0360-3997 (Linking)

(2018) Association between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level, and Immunoglobulin G Level in Patients with Neuromyelitis Optica Spectrum Disorder. International Journal of Preventive Medicine. ISSN 2008-7802

(2018) Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis. JAMA Neurol. pp. 1407-1415. ISSN 2168-6157 (Electronic) 2168-6149 (Linking)

(2018) Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran. Multiple Sclerosis and Related Disorders. pp. 161-165. ISSN 2211-0348

(2018) Comparison effect of prescription drugs on the occurrence and the number of attacks in patients with multiple sclerosis. Journal of Isfahan Medical School. pp. 1557-1563. ISSN 10277595 (ISSN)

(2018) Comparison of Fats/Oils Intake and Disability in Patients with MS and Patients with Nmosd. Multiple Sclerosis Journal. p. 82. ISSN 1352-4585

(2018) Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod. Multiple Sclerosis and Related Disorders. pp. 121-123. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2018) Decreased Serum Levels of Interleukin-35 among Multiple Sclerosis Patients May Be Related to Disease Progression. Journal of Biological Regulators and Homeostatic Agents. pp. 1249-1253. ISSN 0393-974x

(2018) Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, Iran. Iran J Neurol. pp. 6-10. ISSN 2008-384X (Print) 2008-384X (Linking)

(2018) Diet and Neuromyelitis Optica Spectrum Disorder; Association between Food Group Intakes and Disability in Patients with Nmosd. Multiple Sclerosis Journal. pp. 80-81. ISSN 1352-4585

(2018) Evaluation of sleep quality and risk assessment of obstructive sleep apnea among patients with MS. Multiple Sclerosis Journal. Np16-Np17. ISSN 1352-4585

(2018) Genetic variation in intergenic and exonic miRNA sequence and risk of multiple sclerosis in the Isfahan patients. Iranian Journal of Allergy, Asthma and Immunology. pp. 477-484. ISSN 17351502 (ISSN)

(2018) High Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction after Thymectomy. NeuroImmunoModulation. pp. 80-88. ISSN 1021-7401

(2018) Immune Thrombocytopenia (ITP) in a Patient with Relapsing-Remitting Multiple Sclerosis (RRMS) Associated with b-Interferon-1 alpha Treatment. Indian Journal of Pharmaceutical Education and Research. pp. 540-542. ISSN 0019-5464

(2018) Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated from Newly Diagnosed and IFN-ss1b-Treated MS Patients. Inflammation. ISSN 1573-2576 (Electronic) 0360-3997 (Linking)

(2018) Increased Proportion of Tc17 and Th17 Cells and Their Significant Reduction after Thymectomy May Be Related to Disease Progression in Myasthenia Gravis. NeuroImmunoModulation. pp. 264-270. ISSN 10217401 (ISSN)

(2018) Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Multiple sclerosis (Houndmills, Basingstoke, England). pp. 642-652. ISSN 1477-0970 (Electronic) 1352-4585 (Linking)

(2018) Lower extremity deep venous thrombosis in a multiple sclerosis patient on dimethyl fumarate. Multiple Sclerosis and Related Disorders. p. 196. ISSN 2211-0348

(2018) Neuromyelitis optica spectrum disorder and menstruation. Rev Neurol (Paris). ISSN 0035-3787 (Print) 0035-3787 (Linking)

(2018) OX40 Gene Expression and its Serum Levels in New Cases of Patients with Multiple Sclerosis. Advances in Neuroimmune Biology. pp. 49-52. ISSN 1878-948x

(2018) OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson's Disease. Cell Journal. pp. 177-182. ISSN 2228-5806

(2018) Phase sensitive reconstruction of T1-weighted inversion recovery in the evaluation of the cervical cord lesions in Multiple Sclerosis; is it similarly eligible in 1.5 T magnet fields? Multiple Sclerosis and Related Disorders. pp. 17-22. ISSN 2211-0348

(2018) Presentation of Neuromyelitis Optica (NMO) in patients from different racial groups: analysis of the global NMOBase Registry. Neurology. ISSN 0028-3878

(2018) Promising effect of rapamycin on multiple sclerosis. Mult Scler Relat Disord. pp. 40-45. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2018) Relationship between Caffeine Intake, EDSS and Fatigue Scale in Patients with Multiple Sclerosis. Multiple Sclerosis Journal. pp. 116-117. ISSN 1352-4585

(2018) Safety of rituximab in NMOSD patients: a long time prospective observational study. Multiple Sclerosis Journal. p. 744. ISSN 1352-4585

(2018) Salt Intake and Disability in Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal. p. 79. ISSN 1352-4585

(2018) Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (MS)-A Longitudinal and Pilot Study. Frontiers in Psychiatry. ISSN 1664-0640

(2018) Vitamin D Supplementation May Have Therapeutic Effects in Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal. pp. 78-79. ISSN 1352-4585

(2018) The interplay of multiple sclerosis and menstrual cycle: Which one affects the other one? Multiple Sclerosis and Related Disorders. pp. 46-50. ISSN 2211-0348

(2018) The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder. Iran J Neurol. pp. 58-63. ISSN 2008-384X (Print) 2008-384X (Linking)

(2017) Association Between Sun Exposure, Vitamin D Intake, Serum Vitamin D Level and Igg-NMO Level in Patients with Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal. p. 346. ISSN 1352-4585

(2017) Cerebrospinal Fluid and Serum Markers of Inflammation in Patients with Multiple Sclerosis. Advances in Neuroimmune Biology. pp. 149-152. ISSN 1878-948X

(2017) Comparison of dietary intakes of vitamin D, sun exposure and serum vitamin D levels in patients with MS, patients with NMOSD and healthy group. Multiple Sclerosis Journal. pp. 38-39. ISSN 1352-4585

(2017) Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial. Multiple Sclerosis Journal. pp. 990-991. ISSN 1352-4585

(2017) Contribution of different relapse phenotypes to disability in multiple sclerosis. Multiple Sclerosis Journal. pp. 266-276. ISSN 1352-4585

(2017) Contribution of inflammation to disability accrual in primary progressive multiple sclerosis. Multiple Sclerosis Journal. pp. 399-401. ISSN 1352-4585

(2017) Decreased serum levels of interleukin-35 among patients with clinically isolated syndrome and relapsing remitting multiple sclerosis. Multiple Sclerosis Journal. p. 1020. ISSN 1352-4585

(2017) Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Multiple Sclerosis and Related Disorders. pp. 144-151. ISSN 2211-0348

(2017) Diet and Multiple Sclerosis; Association between food group intakes and disability in patients with MS. Multiple Sclerosis Journal. p. 40. ISSN 1352-4585

(2017) Dietary intakes of minerals and disability in multiple sclerosis; is there any association? Multiple Sclerosis Journal. pp. 786-787. ISSN 1352-4585

(2017) Dietary intakes of vitamin D, sunshine exposure, EDSS and fatigue scale in Multiple Sclerosis. Are there any correlations? Multiple Sclerosis Journal. p. 41. ISSN 1352-4585

(2017) Disease modifying therapy improves disability outcomes in relapsing-remitting multiple sclerosis over 22 years. Multiple Sclerosis Journal. pp. 361-363. ISSN 1352-4585

(2017) Effect of Auriculotherapy on Multiple Sclerosis Related Pain: A Double Blind Randomized Clinical Control Trial Parallel Design. International Journal of Advanced Biotechnology and Research. pp. 1831-1840. ISSN 0976-2612

(2017) The Effect of Emotional Intelligence Training on Self-efficacy in Women with Multiple Sclerosis. Iranian journal of nursing and midwifery research. pp. 421-426. ISSN 1735-9066 (Print) 1735-9066 (Linking)

(2017) Evaluating the effect of adding Fish oil to Fingolimod on TNF-alpha, IL1 beta, IL6, and IFN-gamma in patients with relapsing-remitting multiple sclerosis: A double-blind randomized placebo-controlled trial. Clinical Neurology and Neurosurgery. pp. 173-178. ISSN 0303-8467

(2017) Evaluation of sleep quality and risk assessment of obstructive sleep apnea among MS patients. Multiple Sclerosis Journal. p. 734. ISSN 1352-4585

(2017) Fats and multiple sclerosis; association between fats/oils intake and disability in patients with MS. Multiple Sclerosis Journal. pp. 787-788. ISSN 1352-4585

(2017) IgG-NMO status after vitamin D supplementation in patients with NMOSD; A case report. Multiple Sclerosis Journal. p. 72. ISSN 1352-4585

(2017) Longitudinal Study of Retinal Nerve Fiber Thickness Among Relapsing Remitting MS Patients After Three Years of Treatment Using Optical Coherence Tomography. Multiple Sclerosis Journal. p. 326. ISSN 1352-4585

(2017) Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study. Journal of Research in Medical Sciences. ISSN 1735-1995

(2017) Novel mutation in HTRA1 identified in a family with diffuse demyelination lesions. Journal of Neurochemistry. p. 94. ISSN 0022-3042

(2017) Possible Relationship between Cytomegalovirus Infection and Neuromyelitis Optica and Multiple Sclerosis. Multiple Sclerosis Journal. pp. 321-322. ISSN 1352-4585

(2017) Prognostic Indicators in Pediatric Clinically Isolated Syndrome. Annals of Neurology. pp. 729-739. ISSN 0364-5134

(2017) Relationship between salt intake, EDSS and fatigue scale in patients with MS. Multiple Sclerosis Journal. pp. 40-41. ISSN 1352-4585

(2017) Timing of high-efficacy disease modifying therapies for relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. pp. 71-73. ISSN 1352-4585

(2017) Towards personalized therapy for multiple sclerosis: prediction of individual treatment response. Brain. pp. 2426-2443. ISSN 0006-8950

(2017) A comparison the effects of reflexology and relaxation on the psychological symptoms in women with multiple sclerosis. Journal of education and health promotion. p. 11. ISSN 2277-9531 (Print) 2277-9531 (Linking)

(2017) The effect of disease-modifying treatments on conversion to secondary progressive multiple sclerosis. Multiple Sclerosis Journal. pp. 32-34. ISSN 1352-4585

(2017) The effect of electronic education on knowledge of patients with multiple sclerosis. Journal of education and health promotion. p. 10. ISSN 2277-9531 (Print) 2277-9531 (Linking)

(2017) The effects of vitamin D supplementation on IgG-NMO titration in patients with Neuromyelitis Optica Spectrum Disorder (NMOSD). Multiple Sclerosis Journal. p. 73. ISSN 1352-4585

(2017) The survey of mindfulness in multiple sclerosis patients and its association with attachment style. Journal of education and health promotion. p. 7. ISSN 2277-9531 (Print) 2277-9531 (Linking)